Pancreatic Cancer Research

ResearcherFudan UniversityActive in the last 2 years

Tongyi Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-4909-6949; OpenAlex author ID A5115604004. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 4

  1. The OAS1-FASN axis promotes pancreatic cancer by coordinating lipogenic stress and the unfolded protein response. Co-author DOI 10.1038/s41419-026-08922-8↗
  2. CASC8 activates the pentose phosphate pathway to inhibit disulfidptosis in pancreatic ductal adenocarcinoma though the c-Myc-GLUT1 axis. Co-author DOI 10.1186/s13046-025-03295-w↗
  3. RET rearrangement-positive pancreatic cancer has remarkable response to pralsetinib: a case report. Co-author DOI 10.3389/fonc.2023.1078076↗
  4. Four drug metabolism-related subgroups of pancreatic adenocarcinoma in prognosis, immune infiltration, and gene mutation. Co-author DOI 10.1515/med-2022-0433↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chunjing Li · 2 shared papers, 2025–2026 · strength 0.53
  2. Chongyi Jiang · 2 shared papers, 2023–2025 · strength 0.47
  3. Zhu Y · 1 shared paper, 2026 · strength 0.30
  4. Chongyi Jiang · 1 shared paper, 2026 · strength 0.30
  5. Zhiwei Cai · 1 shared paper, 2023 · strength 0.24
  6. Hong‐Fei Yao · 1 shared paper, 2025 · strength 0.23
  7. Jiaqi He · 1 shared paper, 2022 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.